The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response.
作者信息
Mullooly Maeve, Gierach Gretchen L
出版信息
JNCI Cancer Spectr. 2018 Nov;2(4):pky072. doi: 10.1093/jncics/pky072. Epub 2019 Jan 29.
Abstract
摘要
相似文献
1
The Potential for Mammographic Breast Density Change as a Biosensor of Adjuvant Tamoxifen Therapy Adherence and Response.乳腺钼靶密度变化作为辅助性他莫昔芬治疗依从性和反应生物传感器的潜力
JNCI Cancer Spectr. 2018 Nov;2(4):pky072. doi: 10.1093/jncics/pky072. Epub 2019 Jan 29.
2
Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.乳腺 X 线摄影密度降低是绝经后乳腺癌患者接受辅助他莫昔芬治疗反应的预后标志物。
J Clin Oncol. 2013 Jun 20;31(18):2249-56. doi: 10.1200/JCO.2012.44.5015. Epub 2013 Apr 22.
3
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.乳腺癌女性的辅助治疗与乳腺钼靶密度变化
JNCI Cancer Spectr. 2019 Jan 29;2(4):pky071. doi: 10.1093/jncics/pky071. eCollection 2018 Oct.
4
Time to Mammographic Density Decrease After Exposure to Tamoxifen.他莫昔芬暴露后乳腺密度降低的时间。
Oncologist. 2022 Jul 5;27(7):e601-e603. doi: 10.1093/oncolo/oyac104.
5
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients.系统辅助治疗和 CYP2D6 活性对接受他莫昔芬治疗的乳腺癌患者乳腺密度的影响。
Breast Cancer Res Treat. 2021 Dec;190(3):451-462. doi: 10.1007/s10549-021-06386-2. Epub 2021 Sep 27.
6
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险：预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
7
Minimal impact of adjuvant exemestane or tamoxifen treatment on mammographic breast density in postmenopausal breast cancer patients: a Dutch TEAM trial analysis.辅助依西美坦或他莫昔芬治疗对绝经后乳腺癌患者乳腺钼靶密度的影响极小：一项荷兰TEAM试验分析
Acta Oncol. 2015 Mar;54(3):349-60. doi: 10.3109/0284186X.2014.964809. Epub 2014 Nov 10.
8
Mammographic Density Reduction as a Prognostic Marker for Postmenopausal Breast Cancer: Results Using a Joint Longitudinal-Survival Modeling Approach.乳腺X线密度降低作为绝经后乳腺癌的预后标志物：采用联合纵向生存建模方法的结果
Am J Epidemiol. 2017 Nov 1;186(9):1065-1073. doi: 10.1093/aje/kwx178.
9
Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.绝经前雌激素受体阳性乳腺癌妇女停用他莫昔芬后乳腺密度的变化。
Eur Radiol. 2018 Aug;28(8):3176-3184. doi: 10.1007/s00330-017-5293-y. Epub 2018 Apr 6.
10
Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial.低剂量他莫昔芬减少乳腺密度：一项随机对照试验。
J Clin Oncol. 2021 Jun 10;39(17):1899-1908. doi: 10.1200/JCO.20.02598. Epub 2021 Mar 18.
引用本文的文献
1
Temporal changes in mammographic breast density and breast cancer risk among women with benign breast disease.良性乳腺疾病女性的乳腺密度和乳腺癌风险的时间变化。
Breast Cancer Res. 2024 Mar 26;26(1):52. doi: 10.1186/s13058-024-01764-2.
2
Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography.通过全乳超声断层扫描评估他莫昔芬治疗后乳腺密度的快速降低。
J Clin Med. 2022 Feb 1;11(3):792. doi: 10.3390/jcm11030792.
3
Mammographic density, endocrine therapy and breast cancer risk: a prognostic and predictive biomarker review.乳腺密度、内分泌治疗与乳腺癌风险：预后和预测生物标志物综述。
Cochrane Database Syst Rev. 2021 Oct 26;10(10):CD013091. doi: 10.1002/14651858.CD013091.pub2.
4
Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials.用于降低绝经前妇女乳腺 X 线摄影密度的化学预防剂：临床试验的系统评价。
JNCI Cancer Spectr. 2021 Jan 22;5(1). doi: 10.1093/jncics/pkaa125. eCollection 2021 Feb.
5
Male breast cancer: A closer look at patient and tumor characteristics and factors associated with survival.男性乳腺癌：对患者和肿瘤特征以及与生存相关因素的更深入观察。
Thorac Cancer. 2020 Nov;11(11):3107-3116. doi: 10.1111/1759-7714.13611. Epub 2020 Sep 15.
6
Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy.乳腺钼靶密度：基质对乳腺癌检测与治疗的影响
J Clin Med. 2020 Mar 12;9(3):776. doi: 10.3390/jcm9030776.
7
Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed.使用全乳超声断层扫描改善乳腺癌风险评估：基于声速定量组织特性的新型风险因素。
J Clin Med. 2020 Jan 29;9(2):367. doi: 10.3390/jcm9020367.
8
Involution of Breast Lobules, Mammographic Breast Density and Prognosis Among Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer Patients.他莫昔芬治疗的雌激素受体阳性乳腺癌患者乳腺小叶退化、乳腺钼靶密度与预后
J Clin Med. 2019 Nov 4;8(11):1868. doi: 10.3390/jcm8111868.
本文引用的文献
1
Adjuvant Therapy and Mammographic Density Changes in Women With Breast Cancer.乳腺癌女性的辅助治疗与乳腺钼靶密度变化
JNCI Cancer Spectr. 2019 Jan 29;2(4):pky071. doi: 10.1093/jncics/pky071. eCollection 2018 Oct.
2
Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.比较乳腺癌风险预测模型的验证及对未来风险分层的预测。
J Natl Cancer Inst. 2020 Mar 1;112(3):278-285. doi: 10.1093/jnci/djz113.
3
Mammographic density changes following discontinuation of tamoxifen in premenopausal women with oestrogen receptor-positive breast cancer.绝经前雌激素受体阳性乳腺癌妇女停用他莫昔芬后乳腺密度的变化。
Eur Radiol. 2018 Aug;28(8):3176-3184. doi: 10.1007/s00330-017-5293-y. Epub 2018 Apr 6.
4
The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study.WECARE 研究中乳腺密度与对侧乳腺癌风险的关系以及治疗过程中密度的变化。
Breast Cancer Res. 2018 Mar 22;20(1):23. doi: 10.1186/s13058-018-0948-4.
5
A comprehensive tool for measuring mammographic density changes over time.一种全面的工具，用于测量随时间变化的乳腺密度变化。
Breast Cancer Res Treat. 2018 Jun;169(2):371-379. doi: 10.1007/s10549-018-4690-5. Epub 2018 Feb 1.
6
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.应用单核苷酸多态性和乳腺 X 线密度与经典危险因素预测乳腺癌风险。
JAMA Oncol. 2018 Apr 1;4(4):476-482. doi: 10.1001/jamaoncol.2017.4881.
7
Current and Future Methods for Measuring Breast Density: A Brief Comparative Review.测量乳腺密度的当前及未来方法：简要比较综述
Breast Cancer Manag. 2015;4(4):209-221. doi: 10.2217/bmt.15.13. Epub 2015 Aug 28.
8
Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.他莫昔芬和芳香化酶抑制剂对乳腺体积密度的纵向影响
Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):930-937. doi: 10.1158/1055-9965.EPI-16-0882. Epub 2017 Feb 1.
9
Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies.乳腺钼靶密度：辅助性及预防性乳腺癌内分泌治疗的一种潜在监测生物标志物。
Oncotarget. 2017 Jan 17;8(3):5578-5591. doi: 10.18632/oncotarget.13484.
10
Using Speed of Sound Imaging to Characterize Breast Density.使用超声成像技术来表征乳腺密度。
Ultrasound Med Biol. 2017 Jan;43(1):91-103. doi: 10.1016/j.ultrasmedbio.2016.08.021. Epub 2016 Sep 29.
Zotero 插件